From Physics to Precision Medicine: Moritz Gerstung Reflects on How AI Is Transforming Cancer Genomics

The European Molecular Biology Laboratory (EMBL) Alumni Chats Series di EMBL Alumni Relations

Note sull'episodio

Moritz Gerstung (EMBL-EBI Group Leader, 2015-2021) speaks with Angus Lamond (EMBL Group Leader, 1987-1995), discussing his transition from physics to computational biology, driven by the complexities of biological systems.

He highlights his work at EMBL-EBI, which focused on cancer genomes and tumour dynamics using next-generation sequencing and AI tools. Moritz emphasised the importance of open data access, citing EMBL's role in storing and sharing genomes. He noted the significant impact of AI in cancer research, including the analysis of tumor microscopy and electronic health records. Moritz also discussed the challenges and potential of AI in healthcare, stressing the need for regulatory frameworks and critical assessment.

This conversation was recorded in July 2025.

Alumni Chat contributors are members of the European Mo ... 

 ...  Leggi dettagli
Parole chiave
Molecular biologycomputational biology